These 3 Stocks are at Most Risk From China's AI Innovation
Wall Street shocked by DeepSeek AI's low-cost, high-performance model using reduced-capacity Nvidia GPUs. Competitors take a hit, but potential for innovation and affordability in AI technology.
5 key investing lessons from recent AI-market mania
Investors should be on high alert for more AI-stock weakness after DeepSeek disrupted markets and sent shares tumbling.
Stocks recover after new cost-effective AI platform sparked a sell-off
The launch of DeepSeek had made investors question whether to allocate capital to higher-cost AI-related companies like Nvidia.
KBC Group NV Acquires 101,655 Shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS)
KBC Group NV grew its holdings in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 3,862.3% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange ...
Apellis Pharmaceuticals (NASDAQ:APLS) Receives “Sector Perform” Rating from Royal Bank of Canada
Royal Bank of Canada reiterated their sector perform rating on shares of Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) in a report released on Wednesday,Benzinga reports. Royal Bank of Canada ...